Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
The Science Behind GHK-Cu Copper Peptide Activates Genes Linked to Youth and Repair GHK-Cu influences over 30% of human genes, responsible for collagen synthesis, antioxidant production, and inflammation control, while down regulating genes linked to aging, oxidative stress and tissue degradation
Storage Requirements Unreconstituted (lyophilized powder) BPC-157 maintains stability for 2 to 3 years at freezer temperatures or 1 to 2 years refrigerated
Still, startling regenerative effects have been seen in animal studies of BPC-157, in particular
Invert the vial and add the correct amount of solution to the syringe
It applies the labels to passing containers
Key findings include: GLP3 monotherapy achieved 22.8-24.2% mean weight reduction at 48 weeks in phase 2 obesity trials (8-12 mg doses) Cagrilintide monotherapy produced 10.8% weight loss over 26 weeks in phase 2 studies (2.4 mg dose) CagriSema combination (cagrilintide + semaglutide) achieved 20.4% weight loss at 68 weeks in phase 3 REDEFINE trials Combination approaches consistently outperformed single-agent therapies across multiple dose ranges Studies demonstrated that 100% of participants receiving GLP3 8 mg or higher achieved at least 5% weight loss, with 75-83% achieving 15% or greater weight reduction[9]
